NORDIC BIOTECH GENERAL PARTNER ApS: Financial statements 2017
CVR: 26270367
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
NORDIC BIOTECH GENERAL PARTNER ApS (CVR 26270367) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 2,361,611 and a net result of DKK 1,838,727 compared with DKK 11,467 the year before. That is an increase of 14,433% compared with the year before. Equity in the 2017 report amounted to DKK 2,120,124. The solvency ratio was 98.6%.
- Gross Profit
- DKK 2,361,611
- Profit/Loss
- DKK 1,838,727
- Equity
- DKK 2,120,124
- Total Assets
- DKK 2,150,124
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 2.4 mio. | 1.8 mio. | 2.1 mio. | - |
| 2016 | - | 16 t. | 11 t. | 281 t. | - |
| 2015 | - | 18 t. | 13 t. | 270 t. | - |
| 2014 | - | 21 t. | 15 t. | 257 t. | - |
| 2013 | - | 22 t. | 16 t. | 242 t. | - |
Official annual report
Keep an eye on NORDIC BIOTECH GENERAL PARTNER ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
NORDIC BIOTECH GENERAL PARTNER ApS has published its annual report for 2016. Gross profit came to DKK 16,250, and the net result was DKK 11,467.
About NORDIC BIOTECH GENERAL PARTNER ApS
NORDIC BIOTECH GENERAL PARTNER ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company is owned by TECH GROWTH INVEST ApS and C. HANSEN INVEST ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 163,699 and a net result of DKK 178,169 compared with DKK 67,346 the year before. Equity in the 2025 report amounted to DKK 1,214,065.